ESC 365 - Hypertrophic cardiomyopathy in female patients is associated with symptomatic heart failure and worse functional and exercise capacity

HFA Premium Access

Hypertrophic cardiomyopathy in female patients is associated with symptomatic heart failure and worse functional and exercise capacity

Session: Myocardial disease - hypertrophic cardiomyopathy 3

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor Y. Wasserstrum (Ramat Gan, IL)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Yishay Wasserstrum

Sheba Medical Center, Ramat Gan (Israel)

0 follower

6 more presentations in this session

Patient-reported outcome measures in wild-type and variant cardiac transthyretin amyloidosis: the ITALY (impact of transthyretin amyloidosis on life quality) study

Speaker: Doctor A. Aimo (Pisa, IT)

Echocardiography machine learning based to improve detection of transthyretin cardiac amyloidosis: the R3M algorithm

Speaker: Doctor A. Fraix (Nancy, FR)

Estimation of the target population of a selective cardiac myosin inhibitor for hypertrophic obstructive cardiomyopathy: Real-life data from the French REMY register.

Speaker: Doctor T. Muresan (Paris, FR)

Relative apical longitudinal strain: a powerful tool to predict outcomes in transthyretin amyloid cardiomyopathy

Speaker: Doctor M. Castro (Guimaraes, PT)

A novel myocardium functional echocardiographic parameter, left ventricular myocardial work, associates with sudden cardiac risk score in patients with hypertrophic cardiomyopathy

Speaker: Doctor G. Racz (Szeged, HU)

Access the full session

Myocardial disease - hypertrophic cardiomyopathy 3

Speakers: Doctor Y. Wasserstrum, Doctor A. Aimo, Doctor A. Fraix, Doctor T. Muresan, Doctor M. Castro...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources